LAVA Therapeutics NV (LVTX) Q2 2023 Earnings

22AugConfirmed
Sep 22
Nov 22
Q1 2023
Q2 2023
-0.61
-0.39
-0.18
0.04

Details

Expected EPS
-0.47
Actual EPS
-0.48
Surprise EPS
-0.01
Surprise Percent
+2.13%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.48 per share for Q2 2023.

0 Comments

Share your thoughts